5 YEARS IN THE MAKING, TARGETED NATIONAL LUNG CANCER SCREENING PROGRAM COMMENCES IN 2025 Lung Foundation Australia CEO talks about opportunity to treat patients presenting at early stage instead of late stage
Australian Health Journal SEGMENT
Filmed in Adelaide | February 2025
INTERVIEWED
Mark Brooke, Chief Executive Officer
Lung Foundation Australia
In February 2025, Australian Health Journal spoke with Mark Brooke, Chief Executive Officer of Lung Foundation Australia, at the 10th Australian Lung Cancer Conference in Adelaide, on the upcoming commencement of the National Lung Cancer Screening Program (NLCSP)
The conference theme, Evolution and Revolution in Lung Cancer, was chosen in recognition of the historic significance of 2025. Mr Brooke emphasised the importance of the National Lung Cancer Screening Program, which is set to begin on July 1st.
The Australian Government’s $267 million investment in the National Lung Cancer Screening Program aims to vastly improve lung cancer detection, treatment, and survivorship. When launched it will be Australia’s first new screening program in over 20 years.
Following a request from the Australian Government, Cancer Australia undertook an enquiry into lung cancer screening, publishing a report that informed the development of the NLCSP.
As the health peak advisory body to the Department of Health and Aged Care, the Lung Foundation aims to amplify the lived experiences of patients within this program. After nearly five years of preparation, the initiative is a crucial step in moving lung cancer diagnoses from late stages (three and four) to early stages (one and two), significantly improving patient care.
Mr Brooke expressed optimism that the timing for this screening program is ideal for Australia, given that lung cancer is the nation’s leading cancer killer. The program’s implementation is particularly challenging because it integrates with General Practice, requiring collaboration from healthcare professionals. While acknowledging potential hurdles, Mr Brooke is confident that the organisation and preparation for the program are well on track.
The program specifically addresses the needs of priority populations, including Aboriginal and Torres Strait Islander communities, who are disproportionately affected by lung cancer. Efforts have been made to provide culturally safe experiences and mobile CT services through partnerships with organisations like Heart of Australia, ensuring access for rural and remote populations.
Over the past five years, the Lung Foundation has collaborated with state governments to support the role of specialist lung cancer nurses. This initiative has proven to enhance timely care and improve patient pathways, ultimately striving for better outcomes in lung cancer treatment.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
